The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intravenous (IV) Solutions Market Research Report 2025

Global Intravenous (IV) Solutions Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1415258

No of Pages : 84

Ask Your Query

Synopsis

Market Analysis and Insights: Global Intravenous (IV) Solutions Market

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.

The global Intravenous (IV) Solutions market size is projected to reach US$ 10420 million by 2028, from US$ 7699.9 million in 2021, at a CAGR of 4.4% during 2022-2028.

Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intravenous (IV) Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intravenous (IV) Solutions market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intravenous (IV) Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intravenous (IV) Solutions market.

Global Intravenous (IV) Solutions Scope and Market Size
Intravenous (IV) Solutions market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Solutions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition

Segment by Application

  • Hospital & Clinics
  • Ambulatory
  • Home Care

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Icu Medical Inc. (U.S.)
  • B. Braun Melsungen Ag (Germany)
  • Fresenius Kabi Ag (Germany)
  • Baxter (U.S.)
  • Amanta Healthcare (India)
  • Terumo Medical Corporation (Tokyo)
  • Grifols S.A. (Spain)
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Market by Application
1.3.1 Global Intravenous (IV) Solutions Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital & Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intravenous (IV) Solutions Market Perspective (2017-2028)
2.2 Intravenous (IV) Solutions Growth Trends by Region
2.2.1 Intravenous (IV) Solutions Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Intravenous (IV) Solutions Historic Market Size by Region (2017-2022)
2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Region (2023-2028)
2.3 Intravenous (IV) Solutions Market Dynamics
2.3.1 Intravenous (IV) Solutions Industry Trends
2.3.2 Intravenous (IV) Solutions Market Drivers
2.3.3 Intravenous (IV) Solutions Market Challenges
2.3.4 Intravenous (IV) Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous (IV) Solutions Players by Revenue
3.1.1 Global Top Intravenous (IV) Solutions Players by Revenue (2017-2022)
3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2017-2022)
3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
3.4 Global Intravenous (IV) Solutions Market Concentration Ratio
3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2021
3.5 Intravenous (IV) Solutions Key Players Head office and Area Served
3.6 Key Players Intravenous (IV) Solutions Product Solution and Service
3.7 Date of Enter into Intravenous (IV) Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Solutions Breakdown Data by Type
4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2017-2022)
4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2023-2028)
5 Intravenous (IV) Solutions Breakdown Data by Application
5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2017-2022)
5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Intravenous (IV) Solutions Market Size (2017-2028)
6.2 North America Intravenous (IV) Solutions Market Size by Country (2017-2022)
6.3 North America Intravenous (IV) Solutions Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Intravenous (IV) Solutions Market Size (2017-2028)
7.2 Europe Intravenous (IV) Solutions Market Size by Country (2017-2022)
7.3 Europe Intravenous (IV) Solutions Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous (IV) Solutions Market Size (2017-2028)
8.2 Asia-Pacific Intravenous (IV) Solutions Market Size by Country (2017-2022)
8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Intravenous (IV) Solutions Market Size (2017-2028)
9.2 Latin America Intravenous (IV) Solutions Market Size by Country (2017-2022)
9.3 Latin America Intravenous (IV) Solutions Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous (IV) Solutions Market Size (2017-2028)
10.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2017-2022)
10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 ICU Medical Inc. (U.S.)
11.1.1 ICU Medical Inc. (U.S.) Company Detail
11.1.2 ICU Medical Inc. (U.S.) Business Overview
11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction
11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.1.5 ICU Medical Inc. (U.S.) Recent Development
11.2 B. Braun Melsungen AG (Germany)
11.2.1 B. Braun Melsungen AG (Germany) Company Detail
11.2.2 B. Braun Melsungen AG (Germany) Business Overview
11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction
11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.2.5 B. Braun Melsungen AG (Germany) Recent Development
11.3 Fresenius Kabi AG (Germany)
11.3.1 Fresenius Kabi AG (Germany) Company Detail
11.3.2 Fresenius Kabi AG (Germany) Business Overview
11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction
11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.3.5 Fresenius Kabi AG (Germany) Recent Development
11.4 Baxter (U.S.)
11.4.1 Baxter (U.S.) Company Detail
11.4.2 Baxter (U.S.) Business Overview
11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction
11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.4.5 Baxter (U.S.) Recent Development
11.5 Amanta Healthcare (India)
11.5.1 Amanta Healthcare (India) Company Detail
11.5.2 Amanta Healthcare (India) Business Overview
11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction
11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.5.5 Amanta Healthcare (India) Recent Development
11.6 Terumo Medical Corporation (Tokyo)
11.6.1 Terumo Medical Corporation (Tokyo) Company Detail
11.6.2 Terumo Medical Corporation (Tokyo) Business Overview
11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction
11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.6.5 Terumo Medical Corporation (Tokyo) Recent Development
11.7 Grifols S.A. (Spain)
11.7.1 Grifols S.A. (Spain) Company Detail
11.7.2 Grifols S.A. (Spain) Business Overview
11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction
11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2017-2022)
11.7.5 Grifols S.A. (Spain) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Peripheral Parenteral Nutrition
Table 3. Key Players of Total Parenteral Nutrition
Table 4. Global Intravenous (IV) Solutions Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Intravenous (IV) Solutions Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Intravenous (IV) Solutions Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Intravenous (IV) Solutions Market Share by Region (2017-2022)
Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Intravenous (IV) Solutions Market Share by Region (2023-2028)
Table 10. Intravenous (IV) Solutions Market Trends
Table 11. Intravenous (IV) Solutions Market Drivers
Table 12. Intravenous (IV) Solutions Market Challenges
Table 13. Intravenous (IV) Solutions Market Restraints
Table 14. Global Intravenous (IV) Solutions Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Intravenous (IV) Solutions Market Share by Players (2017-2022)
Table 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2021)
Table 17. Ranking of Global Top Intravenous (IV) Solutions Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intravenous (IV) Solutions Product Solution and Service
Table 21. Date of Enter into Intravenous (IV) Solutions Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intravenous (IV) Solutions Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2017-2022)
Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2023-2028)
Table 27. Global Intravenous (IV) Solutions Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Intravenous (IV) Solutions Revenue Market Share by Application (2017-2022)
Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Intravenous (IV) Solutions Revenue Market Share by Application (2023-2028)
Table 31. North America Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
Table 41. ICU Medical Inc. (U.S.) Company Detail
Table 42. ICU Medical Inc. (U.S.) Business Overview
Table 43. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product
Table 44. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 45. ICU Medical Inc. (U.S.) Recent Development
Table 46. B. Braun Melsungen AG (Germany) Company Detail
Table 47. B. Braun Melsungen AG (Germany) Business Overview
Table 48. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product
Table 49. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 50. B. Braun Melsungen AG (Germany) Recent Development
Table 51. Fresenius Kabi AG (Germany) Company Detail
Table 52. Fresenius Kabi AG (Germany) Business Overview
Table 53. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product
Table 54. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 55. Fresenius Kabi AG (Germany) Recent Development
Table 56. Baxter (U.S.) Company Detail
Table 57. Baxter (U.S.) Business Overview
Table 58. Baxter (U.S.) Intravenous (IV) Solutions Product
Table 59. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 60. Baxter (U.S.) Recent Development
Table 61. Amanta Healthcare (India) Company Detail
Table 62. Amanta Healthcare (India) Business Overview
Table 63. Amanta Healthcare (India) Intravenous (IV) Solutions Product
Table 64. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 65. Amanta Healthcare (India) Recent Development
Table 66. Terumo Medical Corporation (Tokyo) Company Detail
Table 67. Terumo Medical Corporation (Tokyo) Business Overview
Table 68. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product
Table 69. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 70. Terumo Medical Corporation (Tokyo) Recent Development
Table 71. Grifols S.A. (Spain) Company Detail
Table 72. Grifols S.A. (Spain) Business Overview
Table 73. Grifols S.A. (Spain) Intravenous (IV) Solutions Product
Table 74. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
Table 75. Grifols S.A. (Spain) Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous (IV) Solutions Market Share by Type: 2021 VS 2028
Figure 2. Peripheral Parenteral Nutrition Features
Figure 3. Total Parenteral Nutrition Features
Figure 4. Global Intravenous (IV) Solutions Market Share by Application in 2021 & 2028
Figure 5. Hospital & Clinics Case Studies
Figure 6. Ambulatory Case Studies
Figure 7. Home Care Case Studies
Figure 8. Intravenous (IV) Solutions Report Years Considered
Figure 9. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Intravenous (IV) Solutions Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Intravenous (IV) Solutions Market Share by Region: 2021 VS 2028
Figure 12. Global Intravenous (IV) Solutions Market Share by Players in 2021
Figure 13. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2021
Figure 15. North America Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Intravenous (IV) Solutions Market Share by Country (2017-2028)
Figure 17. United States Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Intravenous (IV) Solutions Market Share by Country (2017-2028)
Figure 21. Germany Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Intravenous (IV) Solutions Market Share by Region (2017-2028)
Figure 29. China Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Intravenous (IV) Solutions Market Share by Country (2017-2028)
Figure 37. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Intravenous (IV) Solutions Market Share by Country (2017-2028)
Figure 41. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 44. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 45. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 46. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 47. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 48. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 49. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock